[HTML][HTML] Safety of an inactivated SARS-CoV-2 vaccine among healthcare workers in Turkey: an online survey

O Baydar, Ş Özen, BÖ Şahin, N Köktürk… - Balkan Medical …, 2022 - ncbi.nlm.nih.gov
Background: As vaccination against coronavirus disase-19 (COVID-19) evolves, hesitancy
has become a problematic issue that has gradually spread worldwide. The main reason for …

BNT162b2 COVID-19 vaccination and its effect on blood pressure

TL Tan, SA Salleh, Z Che Man, MHP Tan, R Kader… - Medicina, 2022 - mdpi.com
Background and Objectives: The objective of this study is to examine the effect of the
BNT162b2 vaccine on systolic blood pressure (SBP), diastolic blood pressure (DBP), mean …

Peripheral facial palsy post SARS-CoV-2 vaccine: a regional pharmacovigilance cases series

M Chamboux, C Simon, F Beau-Salinas, A Maurier… - Therapies, 2023 - Elsevier
Peripheral facial palsy (PFP) is a rare adverse reaction identified from clinical trials of
coronavirus disease 2019 (COVID-19) vaccines (messenger ribonucleic acid [mRNA] and …

Evaluation of blood pressure variation in recovered COVID-19 patients at one-year follow-up: a retrospective cohort study

P Azami, RG Vafa, R Heydarzadeh, M Sadeghi… - BMC Cardiovascular …, 2024 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) has various sequelae, one of
which might be hypertension. We aimed to evaluate COVID-19's impact on blood pressure …

Temporal association of vitreous hemorrhage and hypertension after COVID‐19 mRNA vaccines

T Matsuo, H Noda - Clinical Case Reports, 2022 - Wiley Online Library
Vitreous hemorrhage as common eye presentation and hypertension as common systemic
presentation are difficult to designate whether they are coincidental or causal in terms of …

Hypertensive Crisis Following COVID‐19 Vaccination

E Khani, T Entezari‐Maleki - Journal of Clinical Pharmacology, 2022 - ncbi.nlm.nih.gov
Recently, hypertensive crisis, mainly following messenger RNA (mRNA)-based vaccines,
has raised concerns. Meylan et al1 reported 9 cases with stage III hypertension just a few …

[PDF][PDF] Can COVID-19 vaccines induce premature non-communicable diseases: where are we heading to? Vaccines 2023; 11: 208

A Hromic-Jahjefendic, D Barh, V Uversky, AA Aljabali… - 2023 - repository.lincoln.ac.uk
According to the WHO, as of January 2023, more than 850 million cases and over 6.6 million
deaths from COVID-19 have been reported worldwide. Currently, the death rate has been …

Cardiac complications of COVID-19 vaccination: now we know more

P Verdecchia, S Coiro, F Notaristefano… - European Heart …, 2022 - academic.oup.com
The proliferation of good quality observational studies on the potential adverse effects of
COVID-19 vaccination has greatly increased our knowledge on myocarditis and pericarditis …

[PDF][PDF] Coronavirus disease vaccination in heart failure: No time to waste

J Roncalli, F Roubille, N Lamblin, N Girerd… - Archives of …, 2021 - Elsevier
Background Viral diseases are well-established factors responsible for acute
decompensation in chronic heart failure (CHF)(Fig. 1). The underlying pathophysiology …

[HTML][HTML] Осложнения после вакцинации препаратами против SARS-СoV-2: обзор зарубежной литературы

ЕВ Проскурнина, ДВ Иванов… - Вестник Санкт …, 2023 - cyberleninka.ru
Острая респираторная инфекция, вызываемая коронавирусом SARS-CoV-2, явилась
причиной объявленной в марте 2020 г. пандемии. Для профилактики этого заболевания …